Nerve cells communicate with each other through nerve processes or neurites. The dysfunction of neurites results in the clinical symptoms of dementia such as cognitive decline. Currently we cannot directly monitor degeneration of neurites in the living brain and therefore it is difficult to determine whether therapeutic agents are protective. My goal is to develop a detection system in the blood that will allow us to monitor these changes during disease progression and therapeutic intervention.
Enhancing Pharmacological And Behavioural Support To Reduce Smoking Relapse: A Factorial RCT
Funder
National Health and Medical Research Council
Funding Amount
$939,040.00
Summary
Typically stop smoking services users use a base medicine for 8-12 weeks complemented by counselling, delivered via telephone in Australia. This is effective at helping people stop smoking in the short-term, but after one year most will have relapsed. Effective strategies to prevent smoking relapse are desperately needed. The use of stop smoking medicines beyond 8-12 weeks can help reduce relapse, but research (ours and others), find uptake to be modest. New products that deliver nicotine in va